China Regenerative Medicine International Limited announced that following resignation of Professor Xiong Chengyu as Chief Development Strategy Officer and the chairman of Strategy Committee, Dr. Ray Yip will be appointed as Chief Development Strategy Officer and the chairman of Strategy Committee of the company with effect from 1 January 2019.